Results 21 to 30 of about 61,983 (302)

Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System

open access: yesPharmaceutics, 2023
Nanoparticles have numerous applications as drug carriers in drug delivery. The aim of the study was to produce tamoxifen nanoparticles with a defined size and higher encapsulation for efficient tissue uptake with controlled drug release.
Muzna Ali Khattak   +13 more
doaj   +1 more source

Toward a Lockean Unification of Formal and Traditional Epistemology [PDF]

open access: yes, 2022
Can there be knowledge and rational belief in the absence of a rational degree of confidence? Yes, and cases of "mistuned knowledge" demonstrate this. In this paper we leverage this normative possibility in support of advancing our understanding of the ...
Lee, Matthew Brandon, Silva Jr, Paul
core  

Mucin-Protected Caco-2 Assay to Study Drug Permeation in the Presence of Complex Biorelevant Media

open access: yesPharmaceutics, 2022
The poor solubility and permeability of compounds beyond Lipinski’s Rule of Five (bRo5) are major challenges for cell-based permeability assays. Due to their incompatibility with gastrointestinal components in biorelevant media, the exploration of ...
Dong Ye   +9 more
doaj   +1 more source

Preferred antiretroviral drugs for the next decade of scale up [PDF]

open access: yes, 2012
Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission.
Andrieux-Meyer, Isabelle   +10 more
core   +4 more sources

Pharmacological incompatibility

open access: yesБюллетень сибирской медицины, 2003
In the lecture there have been studied pharmacokinetic and pharmacodynamic mechanisms of drug undesirable interaction at combined pharmacotherapy and have been cited the urgent for general practitioner examples of pharmacological incompatibility.
A. I. Vengerovsky
doaj   +1 more source

Application of hot melt extrusion for improving bioavailability of artemisinin a thermolabile drug [PDF]

open access: yes, 2017
Hot melt extrusion has been used to produce a solid dispersion of the thermolabile drug artemisinin. Formulation and process conditions were optimized prior to evaluation of dissolution and biopharmaceutical performance.
A. L. Kelly   +8 more
core   +2 more sources

Drug incompatibility in the ICU: review of implications in nursing practice

open access: yesRevista Eletrônica de Enfermagem, 2017
This is an integrative review of the literature performed in seven databases, with the aim of analyzing the scientific production on potential drug incompatibilities in ICUs, and mapping the most prevalent incompatible drugs described in the literature ...
Graciele Oroski Paes   +3 more
doaj   +1 more source

Genome Sequence of the Chestnut Blight Fungus Cryphonectria parasitica EP155: A Fundamental Resource for an Archetypical Invasive Plant Pathogen. [PDF]

open access: yes, 2020
Cryphonectria parasitica is the causal agent of chestnut blight, a fungal disease that almost entirely eliminated mature American chestnut from North America over a 50-year period. Here, we formally report the genome of C. parasitica EP155 using a Sanger
Aerts, Andrea   +14 more
core  

Electrostatic attraction between cationic-anionic assemblies with surface compositional heterogeneities

open access: yes, 2006
Electrostatics plays a key role in biomolecular assembly. Oppositely charged biomolecules, for instance, can co-assembled into functional units, such as DNA and histone proteins into nucleosomes and actin-binding protein complexes into cytoskeleton ...
Barrat J. L.   +5 more
core   +1 more source

Pattern formation on the surface of cationic-anionic cylindrical aggregates

open access: yes, 2005
Charged pattern formation on the surfaces of self--assembled cylindrical micelles formed from oppositely charged heterogeneous molecules such as cationic and anionic peptide amphiphiles is investigated.
A. Ben-Naim   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy